Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Share-based Compensation: 2009-2024

Historic Share-based Compensation for Select Medical Holdings (SEM) over the last 16 years, with FY2024 value amounting to $100.7 million.

  • Select Medical Holdings' Share-based Compensation fell 6818.93% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.1 million, marking a year-over-year decrease of 6849.38%. This contributed to the annual value of $100.7 million for FY2024, which is 12979.3% up from last year.
  • Select Medical Holdings' Share-based Compensation amounted to $100.7 million in FY2024, which was up 12979.3% from $43.8 million recorded in FY2023.
  • In the past 5 years, Select Medical Holdings' Share-based Compensation ranged from a high of $100.7 million in FY2024 and a low of $27.2 million during FY2020
  • In the last 5 years, Select Medical Holdings' Share-based Compensation had a median value of $37.8 million in 2022 and averaged $48.1 million.
  • Its Share-based Compensation has fluctuated over the past 5 years, first soared by 302.07% in 2020, then surged by 12979.3% in 2024.
  • Select Medical Holdings' Share-based Compensation (Annual) stood at $27.2 million in 2020, then rose by 13.54% to $30.9 million in 2021, then grew by 22.03% to $37.8 million in 2022, then increased by 16.03% to $43.8 million in 2023, then surged by 129.79% to $100.7 million in 2024.
  • Its Share-based Compensation was $100.7 million in FY2024, compared to $43.8 million in FY2023 and $37.8 million in FY2022.